NCT00756548

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 386 (actual)
• Sponsor: Braintree Laboratories · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized, parallel, multi-center, single-blind study, comparing BLI850 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.

Conditions

• Colon Cancer

Interventions

Type	Name	Description
DRUG	BLI850	multi-dose preparation for oral administration prior to colonoscopy
DRUG	polyethylene glycol 3350 based bowel preparation	multi-dose preparation for oral administration prior to colonoscopy

Timeline

• Start date: 2008-08-01
• Primary completion: 2008-11-01
• First posted: 2008-09-22
• Last updated: 2013-12-27
• Results posted: 2013-12-27

Locations

12 sites across 1 country: United States